Prepare an agenda for a sales call
Preparing an agenda in advance of the sales call keeps the meeting on track and ensures that you won't forget to cover all the issues.
Preparing an agenda in advance of the sales call keeps the meeting on track and ensures that you won't forget to cover all the issues. It's helpful to hand a copy of your agenda to your customer so that you are both tracking together. This also alleviates, to some extent, the discomfort of broaching a controversial subject.
Of course, your copy of the agenda may have personal notes that will serve as cues for you during the meeting. In scripting these, the best strategy is to anticipate, anticipate, anticipate. Always play the devil's advocate when preparing your agenda and cues. Ask yourself: What are the hot buttons on this call? What could be some objections or concerns? And prepare your cues accordingly.
Preparing an agenda is also helpful in determining what materials you will need for the meeting. You are inundated with promotional materials, brochures and samples, and it can become tiresome lugging them around. Too often we "wing it," assuring ourselves that samples and promotional items aren't really going to make or break the meeting.
However, visual aids can effectively enhance any sales call. Whether it is a journal reprint, a brochure or samples, a visual aid does make a more cogent impact than mere conversation.
Salespeople have several options for transporting sales materials, such as rolling cases, hand-held cases and luggage carts. But whatever you choose, don't compromise the call - bring it all! PR
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Study: GLP-1, SGLT2s Linked to Reduced Alzheimer Disease Risk in Patients with Type 2 Diabetes
April 17th 2025A new study found that patients with type 2 diabetes treated with GLP-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors demonstrated lower risks of developing Alzheimer disease compared to other glucose-lowering drugs.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
New Insights Into T Cell Exhaustion and Inflammation in Long COVID
April 17th 2025Nigel McCracken, chief operating officer, Virax Biolabs, discusses new findings that reveal altered cytokine activity and evidence of T cell exhaustion in long COVID patients, providing deeper insight into post-infection immune disruption.
